Haas, R., Schmid, H., Hahn, U., Hohaus, S., Goldschmidt, H., Murea, S., . . . Hunstein, W. (1997). Tandem high-dose therapy with ifosfamide, epirubicin, carboplatin and peripheral blood stem cell support is an effective adjuvant treatment for high-risk primary breast cancer. European journal of cancer, 33(3), . https://doi.org/10.1016/S0959-8049(97)89008-9
Chicago-Zitierstil (17. Ausg.)Haas, Rainer, et al. "Tandem High-dose Therapy with Ifosfamide, Epirubicin, Carboplatin and Peripheral Blood Stem Cell Support Is an Effective Adjuvant Treatment for High-risk Primary Breast Cancer." European Journal of Cancer 33, no. 3 (1997). https://doi.org/10.1016/S0959-8049(97)89008-9.
MLA-Zitierstil (9. Ausg.)Haas, Rainer, et al. "Tandem High-dose Therapy with Ifosfamide, Epirubicin, Carboplatin and Peripheral Blood Stem Cell Support Is an Effective Adjuvant Treatment for High-risk Primary Breast Cancer." European Journal of Cancer, vol. 33, no. 3, 1997, https://doi.org/10.1016/S0959-8049(97)89008-9.